RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,341,445 | -33.0% | 1,943,097 | 0.0% | 0.54% | -22.8% |
| Q2 2023 | $24,405,298 | -23.7% | 1,943,097 | 0.0% | 0.71% | -25.3% |
| Q1 2023 | $32,002,807 | +10.2% | 1,943,097 | 0.0% | 0.94% | +16.0% |
| Q4 2022 | $29,029,869 | -33.2% | 1,943,097 | 0.0% | 0.82% | -35.4% |
| Q3 2022 | $43,467,000 | +33.6% | 1,943,097 | 0.0% | 1.26% | +23.7% |
| Q2 2022 | $32,546,000 | -44.0% | 1,943,097 | 0.0% | 1.02% | -12.5% |
| Q1 2022 | $58,156,000 | -51.3% | 1,943,097 | -50.0% | 1.16% | +26.6% |
| Q4 2021 | $119,344,000 | +94.8% | 3,886,194 | +100.0% | 0.92% | +3.4% |
| Q3 2021 | $61,266,000 | -58.5% | 1,943,097 | -51.9% | 0.89% | -7.2% |
| Q2 2021 | $147,684,000 | +111.7% | 4,036,194 | +100.0% | 0.96% | +8.7% |
| Q1 2021 | $69,766,000 | -27.9% | 2,018,097 | -13.4% | 0.88% | -15.1% |
| Q4 2020 | $96,810,000 | -2.4% | 2,329,407 | 0.0% | 1.04% | -28.2% |
| Q3 2020 | $99,209,000 | – | 2,329,407 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |